Total Payments
$201,861
2020 Payments
$423.10
Companies
28
Transactions
301
Medicare Patients
863
Medicare Billing
$75,892
Payment Breakdown by Category
Research$187,735 (93.0%)
Consulting$5,855 (2.9%)
Food & Beverage$5,383 (2.7%)
Travel$2,880 (1.4%)
Education$7.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $187,735 | 20 | 93.0% |
| Consulting Fee | $5,855 | 3 | 2.9% |
| Food and Beverage | $5,383 | 269 | 2.7% |
| Travel and Lodging | $2,880 | 7 | 1.4% |
| Education | $7.59 | 2 | 0.0% |
Payments by Type
Research
$187,735
20 transactions
General
$14,126
281 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| 3M Company | $162,086 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $23,482 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $7,926 | 38 | $0 (2020) |
| GlaxoSmithKline, LLC. | $4,349 | 93 | $0 (2020) |
| Circassia Pharmaceuticals Inc | $1,009 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $390.71 | 12 | $0 (2020) |
| Fisher & Paykel Healthcare Inc | $254.44 | 7 | $0 (2019) |
| GENZYME CORPORATION | $232.19 | 10 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $221.88 | 10 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $213.23 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $423.10 | 23 | GENZYME CORPORATION ($143.10) |
| 2019 | $1,786 | 81 | AstraZeneca Pharmaceuticals LP ($232.61) |
| 2018 | $33,051 | 89 | 3M Company ($29,357) |
| 2017 | $166,601 | 108 | 3M Company ($132,729) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2020 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $54.57 | General |
| 07/29/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2020 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Immunology | ||||||
| 03/04/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/27/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: DERMATOLOGY | ||||||
| 02/24/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory and Allergy | ||||||
| 02/21/2020 | GlaxoSmithKline, LLC. | BREO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $99.61 | General |
| Category: Immunology | ||||||
| 02/18/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Respiratory | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: RESPIRATORY | ||||||
| 02/11/2020 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 02/07/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Respiratory | ||||||
| 02/04/2020 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 01/28/2020 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: RESPIRATORY | ||||||
| 01/21/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2020 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Immunology | ||||||
| 01/10/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: RESPIRATORY | ||||||
| 01/07/2020 | Jazz Pharmaceuticals Inc. | XYREM (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROLOGY | ||||||
| 01/02/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/17/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CSP-07-000034 | 3M Company | $162,086 | 2 |
| BDB-AS-302 | Teva Pharmaceuticals USA, Inc. | $18,824 | 5 |
| FSS-AS-30003 | Teva Pharmaceuticals USA, Inc. | $4,500 | 1 |
| A Randomised PhIII study to assess the effect of 100 mg SC Mepolizumab in the nasal polyp score and symptoms in subjects with bilateral Nasal polyps NP and in current need of NP surgery | GlaxoSmithKline, LLC. | $1,403 | 9 |
| An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment | Circassia Pharmaceuticals Inc | $596.30 | 2 |
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $326.20 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 16 | 863 | 2,386 | $149,602 | $75,892 |
Total Patients
863
Total Services
2,386
Medicare Billing
$75,892
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 365 | 805 | $92,575 | $54,926 | 59.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 46 | 62 | $9,300 | $6,110 | 65.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 49 | 555 | $13,875 | $3,736 | 26.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $5,775 | $2,596 | 45.0% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 83 | 112 | $8,960 | $1,961 | 21.9% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 41 | 186 | $3,348 | $1,611 | 48.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 29 | $2,320 | $1,188 | 51.2% |
| 70210 | X-ray of paranasal sinus, less than 3 views | Office | 2020 | 40 | 49 | $3,185 | $761.51 | 23.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 29 | 31 | $2,325 | $645.09 | 27.7% |
| 70220 | X-ray of paranasal sinus, complete, minimum of 3 views | Office | 2020 | 24 | 24 | $2,280 | $543.78 | 23.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 13 | 14 | $1,330 | $500.21 | 37.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 36 | 50 | $1,500 | $403.12 | 26.9% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 13 | 14 | $457.00 | $358.53 | 78.5% |
| 92557 | Air and bone conduction assessment of hearing loss and speech recognition | Office | 2020 | 18 | 18 | $1,080 | $330.63 | 30.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 12 | $312.00 | $192.52 | 61.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 35 | 392 | $980.00 | $28.72 | 2.9% |
About Dr. John Given, M.D
Dr. John Given, M.D is a Pulmonary Disease healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588779748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Given, M.D has received a total of $201,861 in payments from pharmaceutical and medical device companies, with $423.10 received in 2020. These payments were reported across 301 transactions from 28 companies. The most common payment nature is "" ($187,735).
As a Medicare-enrolled provider, Given has provided services to 863 Medicare beneficiaries, totaling 2,386 services with total Medicare billing of $75,892. Data is available for 1 year (2020–2020), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Allergy & Immunology
- Location Canton, OH
- Active Since 08/20/2006
- Last Updated 04/08/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588779748
Products in Payments
- QVAR (Drug) $18,856
- FLUTICASONE PROPIONATE (Drug) $4,500
- NUCALA (Biological) $1,964
- BEVESPI AEROSPHERE (Drug) $368.53
- DUPIXENT (Biological) $332.25
- SYMBICORT (Drug) $284.81
- ANORO (Drug) $265.18
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $254.44
- FASENRA (Drug) $202.23
- XOLAIR (Biological) $178.39
- Xyrem (Drug) $140.95
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $125.26
- EUCRISA (Drug) $124.15
- TRELEGY ELLIPTA (Drug) $114.24
- Rebif (Biological) $111.58
- BELSOMRA (Drug) $108.41
- Xolair (Biological) $106.80
- FEVIPIPRANT (Drug) $105.06
- Xhance (Drug) $103.19
- Briviact (Drug) $99.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Canton
Spencer Lee, M.d, M.D
Pulmonary Disease — Payments: $7,977
Pulmonary Disease $7,977
Akhil Vallabhaneni, Md, MD
Pulmonary Disease — Payments: $7,793
Pulmonary Disease $7,793
Jose Antony Paul, Md, MD
Pulmonary Disease — Payments: $5,289
Pulmonary Disease $5,289
Mrs. Jill Rossrucker, M.d, M.D
Pulmonary Disease — Payments: $3,369
Pulmonary Disease $3,369
Craig Rosebrock, M.d, M.D
Pulmonary Disease — Payments: $1,786
Pulmonary Disease $1,786
Dr. Mohamad Raslan, M.d, M.D
Pulmonary Disease — Payments: $1,316
Pulmonary Disease $1,316